Appeals under way as EC and EMA reject decision that ousted Rasi
This article was originally published in SRA
Executive Summary
One of last year's most disruptive events for the European Medicines Agency was the loss of its executive director Guido Rasi, who had to step aside in November after the EU's civil service tribunal annulled the procedure that led to his appointment in 2011.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.